July 24, 2025

Michael Platten Appointed “Ambassador” of European Research Council

Michael Platten Appointed “Ambassador” of European Research Council

The scientist from Heidelberg University is to boost trust in the funding of innovative research

Prof. Dr Michael Platten has been appointed “Ambassador for the ERC” in order to engage with the public and decision-makers about the importance of groundbreaking research and its benefit for society and industry. The neurologist is one of two scientists in Germany selected for this ambassador network by the European Research Council (ERC) and the Association of ERC Grantees (AERG). A total of 32 outstanding researchers funded with an ERC Grant have been appointed ambassadors. Michael Platten, holder of a professorship at the Medical Faculty Mannheim of Heidelberg University, works at Mannheim University Hospital and the German Cancer Research Center (DKFZ).

Porträt Michael Platten
Michael Platten | © Medizinische Fakultät Mannheim der Universität Heidelberg

In his function as ERC ambassador in Germany, Prof. Platten is mandated to contribute to communicating the value of basic research to political decision-makers, the media, and the public. This includes highlighting the contribution it makes in dealing with societal, economic, environmental and political challenges. Another key concern is to boost trust in funding for innovative research. At the same time, the scientist is a contact partner for European Research Council grantees and he is expected to inform talented researchers about the financial opportunities offered by the ERC. The office of ambassador is initially for one year and can be extended up to six times.

Michael Platten is the director of the Department of Neurology at Mannheim University Hospital and director of the Mannheim Center for Translational Neuroscience, located at the Medical Faculty Mannheim of Heidelberg University. In addition, he heads the Clinical Cooperation Unit Neuroimmunology and Brain Tumor Immunology at the German Cancer Research Center. In 2024 he received an ERC Advanced Grant, which funds groundbreaking research projects. In the framework of his ERC project at the DKFZ, Prof. Platten and his team are working on developing and optimizing personalized cell-based, AI-controlled immunotherapies for malignant brain tumors.

The European Research Council is an institution established by the European Commission to finance frontier research – groundbreaking, visionary research that crosses classical borders. The Association of ERC Grantees is an international organization with a current membership of approx. 10,000 ERC grantees past and present. The ERC and AERG hope to expand the “Ambassadors for the ERC” network in the future to more European Union member states and associated countries.

Our latest News

discover more
PRAME-specific T-cell therapy in an adolescent with metastatic kidney tumor

PRAME-specific T-cell therapy in an adolescent with metastatic kidney tumor

Researchers and physicians at the Hopp Children’s Cancer Center Heidelberg (KiTZ) and other leading cancer centers report an exceptional treatment success in an adolescent with an advanced, therapy-resistant kidney tumor. Using a novel, personalized T-cell therapy, they succeeded in completely pushing back the tumor disease despite multiple metastases. The individual compassionate-use treatment has now been […]

Ascendis to Report Second Quarter 2026 Financial Results and Provide Business Update on August 13, 2026

Ascendis to Report Second Quarter 2026 Financial Results and Provide Business Update on August 13, 2026

COPENHAGEN, Denmark, Aug. 06, 2026 (GLOBE NEWSWIRE) — Ascendis Pharma A/S (Nasdaq: ASND) today announced it plans to report second quarter 2026 financial results and provide a business update on Thursday, August 13, 2026, before the open of the U.S. financial markets. Ascendis Pharma also plans to host a conference call and live webcast on August 13, 2026, at 8:00 a.m. Eastern Time (ET) to discuss […]

Can Protein Building Blocks Protect Against Vascular and Kidney Damage?

Can Protein Building Blocks Protect Against Vascular and Kidney Damage?

Researchers from the Medical Faculty Heidelberg, the Medical Faculty Mannheim, and the Centre for Organismal Studies (COS) at Heidelberg University have launched a new research project investigating so-called dipeptides. Some of these naturally occurring protein building blocks are able to neutralize toxic metabolic by-products and may therefore help protect against vascular and kidney damage, particularly […]

GET IN TOUCH

Stay Updated with bioRN’s Newsletter

Sign up for our newsletter to discover more!
* required

BioRN (BioRN Network e.V. and BioRN Cluster Management GmbH) will use the information you provide on this form to be in touch with you and to provide updates and marketing. Please let us know all the ways you would like to hear from us:

You can update your subscription preferences or unsubscribe at any time. Just follow the unsubscribe or update link in the footer of automated emails you receive from us, or by contacting us at info@biorn.org. We will treat your information with respect. For more information about our privacy practices please visit our website: www.biorn.org. By clicking below, you agree that we may process your information in accordance with these terms.

We use Mailchimp as our marketing platform. By clicking below to subscribe, you acknowledge that your information will be transferred to Mailchimp for processing. Learn more about Mailchimp's privacy practices.

Intuit Mailchimp